Skip to main content

UBS Group AG

Position in ENVB — Enveric Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in ENVB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$276
-$6,728 QoQ
Shares Held
201
-94.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 24 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ENVB ranks #528 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENVB

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $276 201
2026-03-31 $7,004 3,612
2025-12-31 $10,506 2,895
2025-09-30 $67,305 105,333
2025-06-30 $33,079 27,339
2025-03-31 $59,435 42,760
2024-12-31 $28,069 78,408
2024-09-30 $345 731
2024-06-30 $27,268 43,560
2024-03-31 $4,983 4,983
2023-12-31 $13 10
2023-09-30 $739 311
2023-06-30 $181 54
2023-03-31 $8,848 5,318
2022-12-31 $5,003 2,406
2022-09-30 $21,952 5,202
2022-06-30 $101 477
2022-03-31 $32,307 97,904
2021-12-31 $12,986 13,966
2021-09-30 $987 477
2021-06-30 $160,401 67,396
2021-03-31 $96,619 31,472
2020-06-30 AMRH 1,154
2020-03-31 AMRH 5,138